Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Locatelli

Showing results (91-100 of 376) with videos related to

Pageof 38
Sort By:
Contributions to Nephrology|May 7, 2005
What are we expecting to learn from the MPO study?Francesco Locatelli, Pietro Pozzoni, Salvatore Di Filippo
Journal of Nephrology|December 6, 2007
Treating anemia at different stages of renal diseaseFrancesco Locatelli, Lucia Del Vecchio, Pietro Pozzoni
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 22, 2007
Pure red-cell aplasia "epidemic"--mystery completely revealed?Francesco Locatelli, Lucia Del Vecchio, Pietro Pozzoni
Expert Opinion on Drug Safety|December 19, 2023
Cardiovascular safety of current and emerging drugs to treat anaemia in chronic kidney disease: a safety reviewFrancesco Locatelli, Ernesto Paoletti, Lucia Del Vecchio
Hemodialysis International. International Symposium on Home Hemodialysis|February 3, 2016
Serum calcium may not accurately predict intradialytic calcium mass transferSalvatore Di Filippo, Antonio Bellasi, Francesco Locatelli
Clinical Kidney Journal|March 18, 2016
Safety concerns about intravenous iron therapy in patients with chronic kidney diseaseLucia Del Vecchio, Selena Longhi, Francesco Locatelli
Clinical Kidney Journal|October 2, 2023
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitorsFrancesco Locatelli, Lucia Del Vecchio, Steve Elliott
Contributions to Nephrology|July 10, 2002
Clinical experience with darbepoetin-alfa (Aranesp)Francesco Locatelli, Lucia Del Vecchio, Paolo Marai
Nature Clinical Practice. Nephrology|August 26, 2006
IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitorsFrancesco Locatelli, Lucia Del Vecchio, Claudio Pozzi
The New England Journal of Medicine|January 28, 2011
Erythropoietin in kidney disease and type 2 diabetesFrancesco Locatelli, Lucia Del Vecchio, Donatella Casartelli
Pageof 38

Showing results (91-100 of 376) with videos related to

Sort By:
Pageof 38
Contributions to Nephrology|May 7, 2005
What are we expecting to learn from the MPO study?Francesco Locatelli, Pietro Pozzoni, Salvatore Di Filippo
Journal of Nephrology|December 6, 2007
Treating anemia at different stages of renal diseaseFrancesco Locatelli, Lucia Del Vecchio, Pietro Pozzoni
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 22, 2007
Pure red-cell aplasia "epidemic"--mystery completely revealed?Francesco Locatelli, Lucia Del Vecchio, Pietro Pozzoni
Expert Opinion on Drug Safety|December 19, 2023
Cardiovascular safety of current and emerging drugs to treat anaemia in chronic kidney disease: a safety reviewFrancesco Locatelli, Ernesto Paoletti, Lucia Del Vecchio
Hemodialysis International. International Symposium on Home Hemodialysis|February 3, 2016
Serum calcium may not accurately predict intradialytic calcium mass transferSalvatore Di Filippo, Antonio Bellasi, Francesco Locatelli
Clinical Kidney Journal|March 18, 2016
Safety concerns about intravenous iron therapy in patients with chronic kidney diseaseLucia Del Vecchio, Selena Longhi, Francesco Locatelli
Clinical Kidney Journal|October 2, 2023
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitorsFrancesco Locatelli, Lucia Del Vecchio, Steve Elliott
Contributions to Nephrology|July 10, 2002
Clinical experience with darbepoetin-alfa (Aranesp)Francesco Locatelli, Lucia Del Vecchio, Paolo Marai
Nature Clinical Practice. Nephrology|August 26, 2006
IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitorsFrancesco Locatelli, Lucia Del Vecchio, Claudio Pozzi
The New England Journal of Medicine|January 28, 2011
Erythropoietin in kidney disease and type 2 diabetesFrancesco Locatelli, Lucia Del Vecchio, Donatella Casartelli
Pageof 38